Nutra Pharma ships initial product orders of Nyloxin to MyNyloxin
CORAL SPRINGS, Fla. — Nutra Pharma on Tuesday announced that they have begun shipping the initial product orders to MyNyloxin, a new company that has the exclusive rights to market and distribute Nutra Pharma’s over-the-counter pain reliever, Nyloxin, in the network marketing channel.
Nutra Pharma previously announced the launch of the MyNyloxin website that allows for product sales and information as well as allowing distributors to sign up and view the network marketing opportunity. Nutra Pharma will continue to market the products through their retail and direct response distributors.
"Our independent entrepreneurs are excited to begin distributing Nyloxin and sharing this opportunity," said Dalton Johnson, CEO of MyNyloxin.com. "By providing access to a superior pain relief product that customers need and can trust, and by providing an innovative network marketing program that offers a fair and balanced compensation plan for both the average and ambitious MyNyloxin Independent Entrepreneur (MIE), we believe that we will change lives for the better."
Nutra Pharma recently announced the beginning of marketing efforts by New Vitality for the direct response and retail marketing of Nyloxin. New Vitality’s first Nyloxin television commercials are scheduled to begin shortly.
Tory Burch to develop a collection of stylish accessories for Fitbit
LAS VEGAS — Fitbit on Tuesday announced a relationship with Tory Burch to develop a collection of stylish accessory wristbands and necklaces for Fitbit Flex. The Tory Burch for Fitbit accessories collection will include pendants, bracelets and wristbands designed to hold the Fitbit Flex tracker, transforming the activity tracker into a chic accessory for work or weekend, day or evening.
“The fusion of fashion into technology will be an important part of the widespread adoption of wearable technologies, like Fitbit products,” said James Park, CEO of Fitbit. “From the beginning, our success has come not only from offering innovative technology, but from our attention to design, taking into consideration that one-size does not fit all — so partnering with Tory Burch makes perfect sense. We are thrilled to give our users another way to stay active and show off their style at the same time.”
First announced at the 2013 Consumer Electronics Show, the Fitbit Flex wireless activity and sleep-tracking wristband tracks steps taken, distance travelled, calories burned, active minutes and sleep, while syncing wirelessly via Bluetooth 4.0 to iOS and Android devices. Fitbit’s motivational and online tools let users support and inspire each other to lead healthier, more active lives.
The Tory Burch for Fitbit accessories collection is expected to be available in Spring 2014 through Fitbit.com and ToryBurch.com. All accessories will work with Fitbit Flex trackers, sold separately on Fitbit.com and at major retailers for $99.95.
Pairing influenza and pneumococcal vaccination shots for children raises risk of fever
NEW YORK — Giving young children the influenza and pneumococcal vaccines together appears to increase their risk of fever, according to a study led by researchers from Columbia University Medical Center and the Centers for Disease Control and Prevention released Monday afternoon. However, the fever was brief, and medical care was sought for few children, supporting the routine immunization schedule for these vaccines, including the recommendation to administer them simultaneously.
The study, which looked at children 6–23 months old, was published online on Jan. 6, 2014, in Journal of the American Medical Association Pediatrics.
“While our data suggest that giving children the influenza and pneumococcal vaccines together at the same visit increases the risk of fever, compared with getting only one of the vaccines at the visit, these findings should be viewed in context of the benefit of vaccines to prevent serious illness in young children, as well as the recognized need to increase vaccination rates overall,” stated study first author Melissa Stockwell, Florence Irving Assistant Professor of Pediatrics and Population and Family Health at Columbia College of Physicians and Surgeons, with a joint appointment at Columbia’s Mailman School of Public Health. “Parents should be made aware that their child might develop a fever following simultaneous influenza and pneumococcal vaccinations — but that the benefits of these vaccines outweigh the risk of fever and, in most cases, the fever will be brief,” Stockwell said. “For the small group of children who must avoid fever, these findings provide important information for clinicians and parents.”
The study followed 530 children recruited during the 2011–2012 influenza season from three community-based clinics affiliated with New York-Presbyterian and Columbia University Medical Center, who were receiving their usual vaccinations.
After controlling for age and other factors, among children who received simultaneous influenza and pneumococcal vaccines, about a third (37.6%) had a fever of 100.4 F or higher on the day of or day after vaccination, compared with children who received only the pneumococcal (9.5%) or only the influenza (7.5%) vaccine. In other words, children receiving the influenza and pneumococcal vaccine together were about three times as likely to have a fever on the day of or day after vaccination, compared with children who received either vaccine alone.
There were no differences among the groups in rates of fever in the two to seven days after vaccination.
“We are committed to making sure that the safety of vaccines is continuously monitored and to better understanding any potential risks associated with vaccination,” stated Claudia Vellozzi, deputy director of the Immunization Safety Office at the Centers for Disease Control and Prevention, and the study’s senior author. “This study also demonstrates how novel approaches, like text messaging to assess fever following vaccination, can be used to enhance vaccine-safety monitoring.”